Silence Therapeutics Plc said that it has expanded its collaboration with Dainippon Sumitomo Pharma Company of Japan in the area of small interfering RNA (siRNA) delivery to include additional disease targets. Financial details were not disclosed.
Silence Therapeutics Plc said that it has expanded its collaboration with Dainippon Sumitomo Pharma Company of Japan in the area of small interfering RNA (siRNA) delivery to include additional disease targets. Financial details were not disclosed.